EP
Eversept Partners Portfolio holdings
AUM
$992M
This Quarter Return
+5.81%
1 Year Return
+2.54%
3 Year Return
+103.47%
5 Year Return
+181.01%
10 Year Return
–
AUM
$947M
AUM Growth
+$947M
(-15%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-14.16%
Top 10 Holdings %
Top 10 Hldgs %
57.65%
Holding
77
New
15
Increased
20
Reduced
27
Closed
7
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$26.8M |
| 2 |
HCA Healthcare
HCA
|
$16M |
| 3 |
Bio-Techne
TECH
|
$12.6M |
| 4 |
Krystal Biotech
KRYS
|
$12.5M |
| 5 |
ABCM
Abcam plc American Depositary Shares
ABCM
|
$12.2M |
Top Sells
| 1 |
Biogen
BIIB
|
$42.8M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$35.4M |
| 3 |
GSK
GSK
|
$30.6M |
| 4 |
Natera
NTRA
|
$19.8M |
| 5 |
AMED
Amedisys
AMED
|
$16.5M |
Sector Composition
| 1 | Healthcare | 98.52% |
| 2 | Communication Services | 0.83% |
| 3 | Financials | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Revvity
RVTY
$9.68B
| $2.53M | 0.21% |
21,314
+8,979
| +73% | +$1.07M |
|
52
Black Diamond Therapeutics
BDTX
$164M
| $2.16M | 0.18% |
+427,317
| New | +$2.16M |
|
53
GoHealth
GOCO
$77.4M
| $2.07M | 0.17% |
104,820
-20,233
| -16% | -$399K |
|
54
Xoma
XOMA
$421M
| $1.7M | 0.14% |
89,950
| – | – |
|
55
Evolus
EOLS
$477M
| $1.66M | 0.14% |
228,679
+7,128
| +3% | +$51.8K |
|
56
argenx
ARGX
$44.2B
| $1.62M | 0.14% |
4,154
+318
| +8% | +$124K |
|
57
Zai Lab
ZLAB
$3.48B
| $1.53M | 0.13% |
55,176
-116,823
| -68% | -$3.24M |
|
58
Elevance Health
ELV
$72.4B
| $1.03M | 0.09% |
2,315
-18,300
| -89% | -$8.13M |
|
|
AFMD
59
DELISTED
Affimed
AFMD
| $1M | 0.08% |
167,668
-20,710
| -11% | -$124K |
|
60
Gossamer Bio
GOSS
$587M
| $900K | 0.08% |
749,697
-602,368
| -45% | -$723K |
|
|
JBIO
61
Jade Biosciences, Inc. Common Stock
JBIO
$245M
| $862K | 0.07% |
1,435
| – | – |
|
62
UroGen Pharma
URGN
$896M
| $774K | 0.06% |
+74,797
| New | +$774K |
|
|
WHWK
63
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
| $697K | 0.06% |
101,918
| – | – |
|
64
AC Immune
ACIU
$227M
| $368K | 0.03% |
124,589
| – | – |
|
65
ARS Pharmaceuticals
SPRY
$1.08B
| $327K | 0.03% |
+48,788
| New | +$327K |
|
66
FibroGen
FGEN
$48.4M
| $15.1K | ﹤0.01% |
+224
| New | +$15.1K |
|
67
Invesco QQQ Trust
QQQ
$364B
| – | – |
0
| – | – |
|
|
AMED
68
DELISTED
Amedisys
AMED
| – | – |
-224,263
| Closed | -$16.5M |
|
69
AMN Healthcare
AMN
$760M
| – | – |
0
| – | – |
|
70
Avantor
AVTR
$8.74B
| – | – |
-717,614
| Closed | -$15.2M |
|
|
71
Biogen
BIIB
$20.8B
| – | – |
-153,774
| Closed | -$42.8M |
|
72
Guardant Health
GH
$8.11B
| – | – |
-483,098
| Closed | -$11.3M |
|
73
SPDR S&P 500 ETF Trust
SPY
$656B
| – | – |
0
| – | – |
|
74
Tenet Healthcare
THC
$16.5B
| – | – |
-141,892
| Closed | -$8.43M |
|
75
SPDR S&P Biotech ETF
XBI
$5.29B
| – | – |
0
| – | – |
|